Research report library

Verified research paths for 200 stocks

Find earnings context, catalysts, risks, valuation interpretation, and sources by stock. Verified public research is clearly separated from AI report demonstrations.

Verified stocks
200
Sectors covered
18
Verified sources
621

Product format demonstrations

See how an AI report is organized

These three items are demonstrations, not live investment conclusions. Generated results remain in the signed-in workspace.

NVDA

DEMO DATA

NVIDIA Corp.

BUY
Confidence
HIGH
Risk
MEDIUM

AlphaVue's sample conclusion for NVDA is **BUY / HIGH CONFIDENCE / MEDIUM RISK**. The edge comes from a rare combination of earnings strength, strategic positioning, and still-intact price structure. The main risk is not that the business suddenly deteriorates, but that expectations have climbed so high that the stock can temporarily de-rate on merely good news. This remains a strong trend name, but one that still requires disciplined sizing.

Generate my NVDA report

TSLA

DEMO DATA

Tesla Inc.

HOLD
Confidence
MEDIUM
Risk
HIGH

AlphaVue's sample conclusion for TSLA is **HOLD / MEDIUM CONFIDENCE / HIGH RISK**. That does not mean there is no upside. It means the stock is still better suited for observation and tactical participation than for high-conviction heavy sizing. The next meaningful trend leg will depend less on excitement and more on whether margins, deliveries, and autonomy milestones can begin reinforcing each other again.

Generate my TSLA report

AAPL

DEMO DATA

Apple Inc.

HOLD
Confidence
MEDIUM
Risk
LOW

AlphaVue's sample conclusion for AAPL is **HOLD / MEDIUM CONFIDENCE / LOW RISK**. The company remains exceptionally strong, but the stock currently looks more like a durable compounder than a near-term breakout candidate. It deserves a place on the shortlist and often in the portfolio, but not necessarily as the highest-conviction new entry at current levels.

Generate my AAPL report

Verified public research

Browse all 200 stocks

Every entry links to its canonical stock page with company-specific research and verified sources.

200 research profiles
200/200

CVS

CVS Health Corporation

health care · Health Care Services

Primary catalyst

Pricing, benefit redesign and membership actions can improve alignment between premiums and medical costs.

Primary risk

Higher utilization or acuity can outpace pricing and pressure insurance margins.

Q1 20263 verified sourcesReviewed 2026-07-12

CI

The Cigna Group

health care · Managed Health Care

Primary catalyst

Specialty pharmacy, care services and benefit-management scale can deepen relationships with health-plan clients.

Primary risk

New rules on rebates, spread pricing or transparency could reduce benefit-management profitability.

Q1 20263 verified sourcesReviewed 2026-07-12

ELV

Elevance Health, Inc.

health care · Managed Health Care

Primary catalyst

Pharmacy, behavioral-health and care-delivery services can grow within Elevance plans and with external clients.

Primary risk

State rates may lag acuity changes after eligibility redeterminations, compressing margins.

Q1 20263 verified sourcesReviewed 2026-07-12

REGN

Regeneron Pharmaceuticals, Inc.

health care · Biotechnology

Primary catalyst

New indications, age groups and geographies can extend a broad type-2 inflammation franchise.

Primary risk

Biosimilars and rival long-duration therapies can erode EYLEA volume, pricing and share.

Q1 20263 verified sourcesReviewed 2026-07-12

ZTS

Zoetis Inc.

health care · Pharmaceuticals

Primary catalyst

Pet owners' focus on longevity and quality of life can sustain medicines, vaccines and diagnostics demand.

Primary risk

Adverse-event concerns or label changes could slow adoption of important companion-animal products.

Q1 20263 verified sourcesReviewed 2026-07-12

BDX

Becton, Dickinson and Company

health care · Health Care Equipment

Primary catalyst

A broad installed base supports repeat demand for needles, syringes, diagnostic consumables and medication-management supplies.

Primary risk

Carve-out costs, stranded overhead and operational disruption could dilute expected portfolio benefits.

FY2026 Q23 verified sourcesReviewed 2026-07-12

HCA

HCA Healthcare, Inc.

health care · Health Care Facilities

Primary catalyst

Population growth and aging in HCA markets can support inpatient, outpatient and emergency demand.

Primary risk

Medicare, Medicaid and commercial payment changes can lag hospital cost inflation.

Q1 20263 verified sourcesReviewed 2026-07-12

NVO

Novo Nordisk A/S

health care · Pharmaceuticals

Primary catalyst

Greater diagnosis, treatment capacity and reimbursement can expand the addressable obesity population.

Primary risk

Rival efficacy, supply and pricing can pressure share and growth across diabetes and obesity.

Q1 20263 verified sourcesReviewed 2026-07-12

MCK

McKesson Corporation

health care · Health Care Distributors

Primary catalyst

Growth in complex medicines can increase distribution, provider-services and data demand.

Primary risk

Large pharmacy and manufacturer relationships can create contract-renewal and pricing leverage risk.

FY2026 Q43 verified sourcesReviewed 2026-07-12

PH

Parker-Hannifin Corporation

industrials · Industrial Machinery and Supplies

Primary catalyst

Commercial and defense production plus aftermarket demand can sustain Aerospace Systems growth.

Primary risk

Distributor destocking and weaker factory activity can reduce short-cycle orders quickly.

FY2026 Q33 verified sourcesReviewed 2026-07-12

GD

General Dynamics Corporation

industrials · Aerospace and Defense

Primary catalyst

U.S. naval modernization can support long-duration Columbia- and Virginia-class production.

Primary risk

Cost growth and schedule slippage on complex fixed-price programs can reduce margins.

Q1 20263 verified sourcesReviewed 2026-07-12

WM

Waste Management, Inc.

industrials · Environmental and Facilities Services

Primary catalyst

Route density and scarce permitted landfill assets can support price increases above cost inflation.

Primary risk

Weak construction, industrial activity or consumer spending can reduce higher-margin landfill volumes.

Q1 20263 verified sourcesReviewed 2026-07-12

NOC

Northrop Grumman Corporation

industrials · Aerospace and Defense

Primary catalyst

Expanded production capacity and program maturity can support multiyear Aeronautics growth.

Primary risk

Cost growth on complex development programs can require adverse contract adjustments.

Q1 20263 verified sourcesReviewed 2026-07-12

MS

Morgan Stanley

financials · Investment Banking and Brokerage

Primary catalyst

Active advisory, underwriting and trading markets can lift Institutional Securities revenue.

Primary risk

Lower issuance, deal completion or trading activity can quickly reduce revenue.

Q1 20263 verified sourcesReviewed 2026-07-12

BLK

BlackRock, Inc.

financials · Asset Management and Custody Banks

Primary catalyst

Broad ETF, active and cash-management flows can compound recurring base fees.

Primary risk

Market declines and currency moves can reduce assets under management and fees.

Q1 20263 verified sourcesReviewed 2026-07-12

SCHW

The Charles Schwab Corporation

financials · Investment Banking and Brokerage

Primary catalyst

New accounts and client assets can expand the long-term revenue base.

Primary risk

Rate changes and client cash sorting can pressure net interest revenue.

Q1 20263 verified sourcesReviewed 2026-07-12

PGR

The Progressive Corporation

financials · Property and Casualty Insurance

Primary catalyst

Competitive pricing and distribution can sustain personal-lines policy growth.

Primary risk

Repair, medical and litigation inflation can outpace pricing actions.

Q1 20263 verified sourcesReviewed 2026-07-12

CB

Chubb Limited

financials · Property and Casualty Insurance

Primary catalyst

Risk-adjusted pricing and exposure growth can support commercial underwriting income.

Primary risk

Weather and other catastrophes can create large, volatile insured losses.

Q1 20263 verified sourcesReviewed 2026-07-12

MMC

Marsh & McLennan Companies, Inc.

financials · Insurance Brokers

Primary catalyst

Complex risk and insurance markets can sustain demand for placement and advice.

Primary risk

Large acquisitions can create cost, retention and systems-integration risk.

Q1 20263 verified sourcesReviewed 2026-07-12

CME

CME Group Inc.

financials · Financial Exchanges and Data

Primary catalyst

Rate, commodity and geopolitical uncertainty can sustain trading and clearing demand.

Primary risk

Calmer markets can reduce transaction and clearing revenue.

Q1 20263 verified sourcesReviewed 2026-07-12

ICE

Intercontinental Exchange, Inc.

financials · Financial Exchanges and Data

Primary catalyst

Global energy uncertainty can reinforce liquidity in ICE benchmark contracts.

Primary risk

High rates and low origination volumes can delay technology growth.

Q1 20263 verified sourcesReviewed 2026-07-12

COF

Capital One Financial Corporation

financials · Consumer Finance

Primary catalyst

Network ownership and cost synergies can improve strategic control and economics.

Primary risk

Higher delinquencies and charge-offs can pressure card profitability.

Q1 20263 verified sourcesReviewed 2026-07-12

USB

U.S. Bancorp

financials · Regional Banks

Primary catalyst

Merchant, corporate and consumer payments can diversify revenue from lending spreads.

Primary risk

Commercial and consumer losses can rise as borrowers refinance.

Q1 20263 verified sourcesReviewed 2026-07-12

PNC

The PNC Financial Services Group, Inc.

financials · Regional Banks

Primary catalyst

New branches and bankers can broaden deposits and commercial relationships.

Primary risk

Office and leveraged borrowers can create outsized losses in stress.

Q1 20263 verified sourcesReviewed 2026-07-12